Cronos Group Inc. (CRON)

NGM – Цена в реальном времени. Валюта: USD

3.17

+0.09 (2.92%)

Рынок открыт: Aug 12, 2026, 1:52 PM EDT

3.05

-0.03 (-0.97%)

Предыдущая сессия: Aug 11, 2026, 7:54 PM EDT

07.08.2026

Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts

Cronos delivered a Q2 2026 earnings report that met bullish investor expectations. Strong quarterly performance reinforces the investment thesis for CRON's growth trajectory. Management execution and financial results support a positive outlook for CRON.

07.08.2026

Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A

Cronos Group Inc. is rapidly expanding internationally, leveraging European legalization momentum and the CanAdelaar acquisition to become a major European cannabis player. Q2 results showed 58% YoY revenue growth to $53M, with margins benefiting from favorable sales mix and stable operating expenses. CRON maintains a robust balance sheet with nearly $800M in cash and short-term investments versus $56M in current liabilities, supporting buybacks and future M&A.

06.08.2026

Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call Transcript

06.08.2026

Cronos Group Q2 Earnings Call Highlights

Cronos Group NASDAQ: CRON reported record second-quarter net revenue, gross profit and adjusted EBITDA for 2026, supported by growth in Israel, Canada and other international markets, including Germany.

06.08.2026

Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates

Cronos Group (CRON) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.1 per share a year ago.

06.08.2026

Cronos Group Reports 2026 Second Quarter Results

Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis Delivered record net revenue in Canada, with Spinach® maintaining #1 market share in vapes and edibles1 Tenth consecutive quarter of record net revenue in Israel, where PEACE NATURALS® continues to be the #1 cannabis brand2 Generated record net revenue outside Canada and Israel, led by strong demand for PEACE NATURALS® in Germany Repurchased 12.3 million shares in the first half of 2026 TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2026 second quarter business results. “Cronos delivered a record second quarter by organically achieving record net revenue, record gross profit and record Adjusted EBITDA, while also reducing our share count.

05.08.2026

3 Top Canadian Marijuana Stock Picks To Add Value To Your Portfolio

There is a great divide between big cannabis companies like Trulieve cannabis corp. Tilray Holdings Inc., and it's not with each other. The separation is what smaller mom-and-pop cannabis farmers are going to do as the big fish takes over the market. As legal cannabis grows, so does the competition, and this leads to a bittersweet result. For investors and those who hold shares of said big company, it is usually the one that wins in the long run. Marijuana stock investors are focused on companies that show profitability and a path towards change and innovation.

Видео

No Data

There is no data to display

Пресс-релизы

06.08.2026

Cronos Group Inc. (CRON)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Cronos Group Inc. (CRON)

Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts

Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A

Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call Transcript

Cronos Group Q2 Earnings Call Highlights

Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates

Cronos Group Reports 2026 Second Quarter Results

3 Top Canadian Marijuana Stock Picks To Add Value To Your Portfolio

Видео

No Data

Пресс-релизы

Cronos Group Reports 2026 Second Quarter Results

Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts

Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A

Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call Transcript

Cronos Group Q2 Earnings Call Highlights

Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates

Cronos Group Reports 2026 Second Quarter Results

3 Top Canadian Marijuana Stock Picks To Add Value To Your Portfolio

Видео

No Data

Пресс-релизы

Cronos Group Reports 2026 Second Quarter Results

Search stocks

Cronos Group Inc. (CRON)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Cronos Group Inc. (CRON)

Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts

Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A

Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call Transcript

Cronos Group Q2 Earnings Call Highlights

Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates

Cronos Group Reports 2026 Second Quarter Results

3 Top Canadian Marijuana Stock Picks To Add Value To Your Portfolio

Видео

No Data

Пресс-релизы

Cronos Group Reports 2026 Second Quarter Results

Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts

Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A

Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call Transcript

Cronos Group Q2 Earnings Call Highlights

Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates

Cronos Group Reports 2026 Second Quarter Results

3 Top Canadian Marijuana Stock Picks To Add Value To Your Portfolio

Видео

No Data

Пресс-релизы

Cronos Group Reports 2026 Second Quarter Results